Literature DB >> 16749862

Lack of interaction between tauroursodeoxycholate and ATP-binding cassette transporter isoform G2 (ABCG2).

Soniya S Vaidya1, Phillip M Gerk.   

Abstract

Ursodiol (UDCA) is useful for treating several cholestatic hepatic maladies, including intrahepatic cholestasis of pregnancy. Its taurine amidate (TUDC), which accumulates in the bile salt pool, could interact with ABCG2 (ATP-binding cassette transporter isoform G2), which is expressed in various tissues including the canalicular membrane of the hepatocyte and in the apical membrane of the placental syncytiotrophoblast. The purpose of this study was to determine the interaction between TUDC and ABCG2. ABCG2 was expressed in Sf9 cells, and ABCG2-mediated ATP-dependent transport was determined in sucrose-fractionated Sf9 membrane vesicles. The transport of estrone 3-sulfate (E1S) into ABCG2-expressing membranes was ATP-dependent and was much greater in membrane vesicles expressing ABCG2 versus the negative control (empty virus lacking the ABCG2 coding region). To determine whether TUDC affects ABCG2-mediated ATP-dependent transport of E1S, transport activity in the presence of TUDC (20-500 microM) was measured. No significant changes were observed in the ABCG2-mediated ATP-dependent E1S transport. Furthermore, ABCG2-mediated TUDC transport was undetectable. Thus, TUDC does not affect ABCG2-mediated E1S transport and is not an ABCG2 substrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16749862     DOI: 10.1021/mp0600079

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  3 in total

1.  Application of human placental villous tissue explants to study ABC transporter mediated efflux of 2,4-dinitrophenyl-S-glutathione.

Authors:  Soniya S Vaidya; Scott W Walsh; Phillip M Gerk
Journal:  Curr Pharm Biotechnol       Date:  2011-05       Impact factor: 2.837

2.  Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.

Authors:  Ágnes Telbisz; Csilla Hegedüs; András Váradi; Balázs Sarkadi; Csilla Özvegy-Laczka
Journal:  Drug Metab Dispos       Date:  2014-01-02       Impact factor: 3.922

3.  High doses of ursodeoxycholic acid up-regulate the expression of placental breast cancer resistance protein in patients affected by intrahepatic cholestasis of pregnancy.

Authors:  Francesco Azzaroli; Maria Elena Raspanti; Patrizia Simoni; Marco Montagnani; Andrea Lisotti; Paolo Cecinato; Rosario Arena; Giuliana Simonazzi; Antonio Farina; Nicola Rizzo; Giuseppe Mazzella
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.